Cardiac disease in beta-thalassaemia major

Is it reversible?

Mehnaz Atiq, M. Bana, U. S. Ahmed, S. Bano, M. Yousuf, Z. Fadoo, M. Khurshid

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Introduction: The aim of this study was to evaluate the spectrum of cardiac involvement and its outcome in beta-thalassaemia major. Methods: There were 75 patients with a mean age of 13.8 (+/- 5.5) years, of whom 33 were male and 42 were female. Clinical history, examination and laboratory investigations were assessed. Electrocardiograms, chest radiographs and echocardiograms were reviewed. Results: 44 patients had cardiac involvement in the form of left ventricular systolic dysfunction in 17, diastolic dysfunction in 22, pericardial effusion in 12 and pulmonary hypertension in 12 patients. With intense chelation therapy and cardiac medications, the condition of 13 of 17 patients with systolic dysfunction, and four of 22 with diastolic dysfunction, improved. Conclusion: Cardiac disease is a common complication of siderotic disease in thalassaemia major and it can be prevented with regular chelation. This study has shown improved systolic function after regular chelation therapy.

Original languageEnglish (US)
Pages (from-to)693-696
Number of pages4
JournalSingapore Medical Journal
Volume47
Issue number8
StatePublished - Aug 1 2006

Fingerprint

beta-Thalassemia
Heart Diseases
Chelation Therapy
Pericardial Effusion
Left Ventricular Dysfunction
Pulmonary Hypertension
Electrocardiography
Thorax

Keywords

  • Cardiomyopathy
  • Chelation
  • Haemosiderosis
  • Left ventricular dysfunction
  • Thalassaemia major

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Atiq, M., Bana, M., Ahmed, U. S., Bano, S., Yousuf, M., Fadoo, Z., & Khurshid, M. (2006). Cardiac disease in beta-thalassaemia major: Is it reversible? Singapore Medical Journal, 47(8), 693-696.

Cardiac disease in beta-thalassaemia major : Is it reversible? / Atiq, Mehnaz; Bana, M.; Ahmed, U. S.; Bano, S.; Yousuf, M.; Fadoo, Z.; Khurshid, M.

In: Singapore Medical Journal, Vol. 47, No. 8, 01.08.2006, p. 693-696.

Research output: Contribution to journalReview article

Atiq, M, Bana, M, Ahmed, US, Bano, S, Yousuf, M, Fadoo, Z & Khurshid, M 2006, 'Cardiac disease in beta-thalassaemia major: Is it reversible?', Singapore Medical Journal, vol. 47, no. 8, pp. 693-696.
Atiq M, Bana M, Ahmed US, Bano S, Yousuf M, Fadoo Z et al. Cardiac disease in beta-thalassaemia major: Is it reversible? Singapore Medical Journal. 2006 Aug 1;47(8):693-696.
Atiq, Mehnaz ; Bana, M. ; Ahmed, U. S. ; Bano, S. ; Yousuf, M. ; Fadoo, Z. ; Khurshid, M. / Cardiac disease in beta-thalassaemia major : Is it reversible?. In: Singapore Medical Journal. 2006 ; Vol. 47, No. 8. pp. 693-696.
@article{3ed0a5ed96e1405981b9a78d08f76642,
title = "Cardiac disease in beta-thalassaemia major: Is it reversible?",
abstract = "Introduction: The aim of this study was to evaluate the spectrum of cardiac involvement and its outcome in beta-thalassaemia major. Methods: There were 75 patients with a mean age of 13.8 (+/- 5.5) years, of whom 33 were male and 42 were female. Clinical history, examination and laboratory investigations were assessed. Electrocardiograms, chest radiographs and echocardiograms were reviewed. Results: 44 patients had cardiac involvement in the form of left ventricular systolic dysfunction in 17, diastolic dysfunction in 22, pericardial effusion in 12 and pulmonary hypertension in 12 patients. With intense chelation therapy and cardiac medications, the condition of 13 of 17 patients with systolic dysfunction, and four of 22 with diastolic dysfunction, improved. Conclusion: Cardiac disease is a common complication of siderotic disease in thalassaemia major and it can be prevented with regular chelation. This study has shown improved systolic function after regular chelation therapy.",
keywords = "Cardiomyopathy, Chelation, Haemosiderosis, Left ventricular dysfunction, Thalassaemia major",
author = "Mehnaz Atiq and M. Bana and Ahmed, {U. S.} and S. Bano and M. Yousuf and Z. Fadoo and M. Khurshid",
year = "2006",
month = "8",
day = "1",
language = "English (US)",
volume = "47",
pages = "693--696",
journal = "Singapore Medical Journal",
issn = "0037-5675",
publisher = "Singapore Medical Association",
number = "8",

}

TY - JOUR

T1 - Cardiac disease in beta-thalassaemia major

T2 - Is it reversible?

AU - Atiq, Mehnaz

AU - Bana, M.

AU - Ahmed, U. S.

AU - Bano, S.

AU - Yousuf, M.

AU - Fadoo, Z.

AU - Khurshid, M.

PY - 2006/8/1

Y1 - 2006/8/1

N2 - Introduction: The aim of this study was to evaluate the spectrum of cardiac involvement and its outcome in beta-thalassaemia major. Methods: There were 75 patients with a mean age of 13.8 (+/- 5.5) years, of whom 33 were male and 42 were female. Clinical history, examination and laboratory investigations were assessed. Electrocardiograms, chest radiographs and echocardiograms were reviewed. Results: 44 patients had cardiac involvement in the form of left ventricular systolic dysfunction in 17, diastolic dysfunction in 22, pericardial effusion in 12 and pulmonary hypertension in 12 patients. With intense chelation therapy and cardiac medications, the condition of 13 of 17 patients with systolic dysfunction, and four of 22 with diastolic dysfunction, improved. Conclusion: Cardiac disease is a common complication of siderotic disease in thalassaemia major and it can be prevented with regular chelation. This study has shown improved systolic function after regular chelation therapy.

AB - Introduction: The aim of this study was to evaluate the spectrum of cardiac involvement and its outcome in beta-thalassaemia major. Methods: There were 75 patients with a mean age of 13.8 (+/- 5.5) years, of whom 33 were male and 42 were female. Clinical history, examination and laboratory investigations were assessed. Electrocardiograms, chest radiographs and echocardiograms were reviewed. Results: 44 patients had cardiac involvement in the form of left ventricular systolic dysfunction in 17, diastolic dysfunction in 22, pericardial effusion in 12 and pulmonary hypertension in 12 patients. With intense chelation therapy and cardiac medications, the condition of 13 of 17 patients with systolic dysfunction, and four of 22 with diastolic dysfunction, improved. Conclusion: Cardiac disease is a common complication of siderotic disease in thalassaemia major and it can be prevented with regular chelation. This study has shown improved systolic function after regular chelation therapy.

KW - Cardiomyopathy

KW - Chelation

KW - Haemosiderosis

KW - Left ventricular dysfunction

KW - Thalassaemia major

UR - http://www.scopus.com/inward/record.url?scp=33746919607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746919607&partnerID=8YFLogxK

M3 - Review article

VL - 47

SP - 693

EP - 696

JO - Singapore Medical Journal

JF - Singapore Medical Journal

SN - 0037-5675

IS - 8

ER -